Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Stem cell extract is a biologic product developed by Acıbadem Labcell, derived from the secretome or intracellular contents of stem cells. This product contains a concentrated cocktail of bioactive molecules, including growth factors, cytokines, and extracellular vesicles (exosomes), which are responsible for the regenerative and immunomodulatory effects typically associated with stem cell therapy. By utilizing the extract rather than live cells, the product aims to provide therapeutic benefits such as tissue repair and anti-inflammatory signaling while potentially reducing the complexities and risks of whole-cell transplantation. It is positioned within Acıbadem Labcell's pipeline for applications in regenerative medicine and immunotherapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on stem cell extract.